SUBSCRIBE
SUBSCRIBE

Sanofi (France)

NEWS
What You Missed: Nippon Fine Chemical Formed Human Barricade to Stop FDA Employee
FDA
Market Just Got More Crowded as Regeneron, Sanofi’s New RA Drug Wins FDA Approval
May 23, 2017
 · 
2 min read
Business
Sanofi To Demolish Unused French Site
May 12, 2017
 · 
1 min read
Deals
After 2 M&A Failures, Sanofi No Longer Feels The Need To Clinch A Deal
May 11, 2017
 · 
1 min read
Biotech Bay
What It’s Like To Work For Drug Giant Sanofi
May 8, 2017
 · 
1 min read
Deals
Sanofi Gives Up On Selling Its $1 Billion Chemical Biz Cepia
May 5, 2017
 · 
1 min read
Deals
How Much Rumored Suitors Like Sanofi Would Have To Pay For Sarepta
May 2, 2017
 · 
1 min read
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Deals
Why M&A Hungry Sanofi Could be Gearing Up to Buy Sarepta
May 1, 2017
 · 
2 min read
Policy
Sanofi Slaps Lawsuit on Mylan Over EpiPen Marketing
April 25, 2017
 · 
1 min read
Deals
Sanofi’s Top Scientist Plays Down Need For Pharma Deals
April 24, 2017
 · 
1 min read
Load More
JOBS
IN THE PRESS
Drug Development
Regeneron And Sanofi Announce Positive Results From First Dedicated Studies Evaluating Praluent (Alirocumab) In Individuals With Diabetes And Hypercholesterolemia
June 12, 2017
 · 
15 min read
Drug Development
New Analysis Shows Sanofi’s Soliqua 100/33 Lowered HbA1c by More Than 2 Percent In Patients With Screening Levels Greater Than 9 Percent
June 12, 2017
 · 
10 min read
Business
ImmunoGen And Sanofi Amend License Agreements
May 30, 2017
 · 
3 min read
Policy
Sanofi Receives CHMP Recommendation For Approval Of Insulin Lispro Biosimilar
May 19, 2017
 · 
5 min read
Business
AI Firm Exscientia Grabs EUR250 Million Small Molecules Pact With Sanofi
May 9, 2017
 · 
3 min read
Deals
Ipsen Completes Acquisition Of Select Consumer Healthcare Products From Sanofi
May 8, 2017
 · 
6 min read
Pharm Country
Sanofi Release: Survey Results Show Eighty Percent Of Rheumatoid Arthritis Patients Report Life-Altering Pain Daily Or Multiple Times A Week, Despite Treatment
May 2, 2017
 · 
7 min read
Business
Sanofi Delivers Robust Q1 2017 Financial Results
April 28, 2017
 · 
8 min read
Policy
Sanofi And Regeneron Announce Kevzara (Sarilumab) Biologics License Application Resubmission Accepted For Review By The FDA
April 28, 2017
 · 
8 min read
Business
Sanofi Delivers Robust Q1 2017 Financial Results
April 28, 2017
 · 
1 min read
Load More